COMMUNIQUÉS West-GlobeNewswire

Ventura Cannabis and Wellness Releases Investor Presentation to Website Ahead of Market Participant Meetings in Toronto
12/03/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, March 12, 2019 (GLOBE NEWSWIRE) -- Ventura [...]
Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc
12/03/2019
COLUMBIA, Md., March 12, 2019 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Generex Biotechnology Announces the Appointment of Chief Commercial Officer
12/03/2019
Lance Goudzwaard Appointed to Head Commercialization and Customer Relations for NuGenerex Distribution Solutions Subsidiary MIRAMAR, FL, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology [...]
Zealand Pharma convenes its Annual General Meeting 2019
12/03/2019
Company Announcement – No. 04/2019 Zealand Pharma convenes its Annual General Meeting 2019 Copenhagen, March 12, 2019 – Zealand Pharma A/S ("Zealand") convenes the Company’s ordinary Annual General Meeting to be held on [...]
Sharps Compliance Appoints Linda Brock as Vice President of Sales
12/03/2019
HOUSTON, March 12, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]
Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model
12/03/2019
Agreement enables greater global model availability for drug discovery in Obesity, Diabetes and Metabolic Syndrome SAN DIEGO, Calif. and WILMINGTON, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global [...]
HX Global Announces Appointment of Tim Crockett as Senior Vice President, US Business Operations
12/03/2019
BOSTON, March 12, 2019 (GLOBE NEWSWIRE) -- HX Global, the Americas division of Healix International, is pleased to announce the appointment of Tim Crockett as Senior Vice President, US Business Operations. This [...]
Anthogyr rejoint le Groupe Straumann
12/03/2019
Straumann Group augmente sa participation dans le fabricant français d'implants Anthogyr de 30% à 100%. Anthogyr, société privée, fournit au Groupe Straumann une gamme supplémentaire de solutions implantaires de haute [...]
Nexstim Plc is planning a rights issue
12/03/2019
Company Announcement, Helsinki, 12 March 2019 at 2.00 pm (EET) Nexstim Plc is planning a Rights Issue Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering [...]
Forty Seven Inc. to Present at Oppenheimer 29th Annual Healthcare Conference
12/03/2019
MENLO PARK, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Join Achieve TMS East to Celebrate the Grand Opening of its Andover Location
12/03/2019
ANDOVER, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression and obsessive-compulsive [...]
Anthogyr joins the Straumann Group
12/03/2019
Straumann Group increases stake in French implant manufacturer Anthogyr from 30% to full ownership Privately-held Anthogyr provides Straumann Group with an additional range of attractively-priced high-quality implant [...]
IBEX Reports Plans to Close Iowa Production Facility
12/03/2019
MONTREAL, March 12, 2019 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that it plans to close its Iowa production facility as of July 31, 2019. The Iowa [...]
Krystal Biotech Reports 2018 Financial Results and Business Progress
12/03/2019
Topline-data from Phase 1/2 clinical trial of KB103 (bercolagene telserpavec) for treatment dystrophic epidermolysis bullosa (DEB) to be announced in 1H 2019 Ancoris, a cGMP facility for clinical and commercial [...]
Bio-Research Products Reports Plans to Close North Liberty Production Facility
12/03/2019
NORTH LIBERTY, Iowa, March 12, 2019 (GLOBE NEWSWIRE) -- Bio-Research Products Inc. today reported that it plans to close its North Liberty production facility as of July 31, 2019. Bio-Research Products (“BRP”) produces [...]
CymaBay Therapeutics to Present at Upcoming Investor Conferences in March
12/03/2019
NEWARK, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
Synthorx to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
12/03/2019
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics [...]
Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18
12/03/2019
Findings from first two cohorts show primary safety endpoint met and early signals of efficacy HAIFA, Israel, March 12, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading [...]
Sport Endurance Completes Transition to Better Choice Company and Begins Trading Under the Symbol ‘BTTR’
12/03/2019
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTC QB: SENZ) announced today that it has received final FINRA approval to complete its reincorporation to Better Choice Company, Inc. (the “Company [...]

Pages